Juan Espinosa‐Pereiro

Impact of the COVID-19 pandemic on tuberculosis management in Spain

María Luisa Aznar, Juan Espinosa‐Pereiro, Núria Saborit et al. · International Journal of Infectious Diseases · 2021 · 78 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +13

Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

Pau Bosch‐Nicolau, Marisa Fernández, Elena Sulleiro et al. · The Lancet Infectious Diseases · 2024 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Tigecycline-associated hypofibrinogenemia in a real-world setting

David Campany, María Larrosa-García, Pilar Lalueza-Broto et al. · International Journal of Clinical Pharmacy · 2020 · 35 citations

Life Sciences, Pharmacotherapy, Pathophysiology +3

Usefulness of FDG PET/CT in the management of tuberculosis

Adrián Sánchez‐Montalvá, Marta Barios, Fernando Salvador et al. · PLoS ONE · 2019 · 34 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Eleftherios Mylonakis, Barnaby Edward Young, David M. Vock et al. · Annals of Internal Medicine · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13